Although lymph node metastasis appears to be regulated by additional factors besides PAR-2, such a cascade of lymph node metastasis might be less active in these cases; resulting in comparatively better patient prognosis. This evidence concerns the gene F2RL1 and metastatic malignant neoplasm in the lymph nodes.